Raymond James & Associates’s Comerica CMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$5.87M Sell
98,002
-47,231
-33% -$2.6M ﹤0.01% 1547
2024
Q2
$7.41M Sell
145,233
-39,560
-21% -$2.02M ﹤0.01% 1340
2024
Q1
$10.2M Sell
184,793
-18,531
-9% -$967K 0.01% 1146
2023
Q4
$11.3M Buy
203,324
+31,125
+18% +$1.41M 0.01% 1030
2023
Q3
$7.15M Buy
172,199
+43,679
+34% +$2.07M 0.01% 1245
2023
Q2
$5.44M Buy
128,520
+87,014
+210% +$3.52M ﹤0.01% 1419
2023
Q1
$1.8M Sell
41,506
-29,565
-42% -$1.89M ﹤0.01% 2093
2022
Q4
$4.75M Buy
71,071
+9,536
+15% +$661K ﹤0.01% 1436
2022
Q3
$4.38M Buy
61,535
+1,708
+3% +$135K ﹤0.01% 1449
2022
Q2
$4.39M Sell
59,827
-7,683
-11% -$621K ﹤0.01% 1481
2022
Q1
$6.11M Sell
67,510
-6,972
-9% -$658K 0.01% 1367
2021
Q4
$6.48M Sell
74,482
-127,663
-63% -$11M 0.01% 1372
2021
Q3
$16.3M Sell
202,145
-15,780
-7% -$1.14M 0.01% 816
2021
Q2
$15.5M Sell
217,925
-39,888
-15% -$2.96M 0.01% 838
2021
Q1
$18.5M Buy
257,813
+161,246
+167% +$10.6M 0.02% 704
2020
Q4
$5.39M Buy
96,567
+50,530
+110% +$2.46M 0.01% 1300
2020
Q3
$1.76M Buy
46,037
+20,000
+77% +$769K ﹤0.01% 1833
2020
Q2
$992K Sell
26,037
-2,813
-10% -$98.1K ﹤0.01% 2168
2020
Q1
$846K Buy
28,850
+2,644
+10% +$144K ﹤0.01% 2093
2019
Q4
$1.88M Buy
26,206
+1,376
+6% +$94.5K ﹤0.01% 1867
2019
Q3
$1.64M Sell
24,830
-57,022
-70% -$3.77M ﹤0.01% 1890
2019
Q2
$5.95M Sell
81,852
-5,951
-7% -$442K 0.01% 1126
2019
Q1
$6.44M Buy
87,803
+23,233
+36% +$1.86M 0.01% 1051
2018
Q4
$4.43M Sell
64,570
-40,126
-38% -$3.19M 0.01% 1173
2018
Q3
$9.44M Buy
104,696
+42,340
+68% +$4.04M 0.01% 857
2018
Q2
$5.67M Buy
62,356
+5,378
+9% +$515K 0.01% 1124
2018
Q1
$5.47M Buy
56,978
+19,452
+52% +$1.85M 0.01% 1106
2017
Q4
$3.26M Buy
37,526
+7,294
+24% +$587K 0.01% 1385
2017
Q3
$2.31M Buy
30,232
+6,431
+27% +$461K ﹤0.01% 1550
2017
Q2
$1.74M Buy
23,801
+3,776
+19% +$265K ﹤0.01% 1657
2017
Q1
$1.37M Sell
20,025
-67,851
-77% -$4.74M ﹤0.01% 1782
2016
Q4
$5.99M Buy
87,876
+77,317
+732% +$4.53M 0.02% 896
2016
Q3
$500K Buy
10,559
+145
+1% +$6.57K ﹤0.01% 2286
2016
Q2
$428K Sell
10,414
-185
-2% -$7.89K ﹤0.01% 2185
2016
Q1
$401K Buy
+10,599
New +$382K ﹤0.01% 2169
2015
Q4
Sell
-13,595
Closed -$559K 2334
2015
Q3
$559K Buy
13,595
+859
+7% +$39.1K ﹤0.01% 1880
2015
Q2
$654K Buy
12,736
+966
+8% +$47K ﹤0.01% 1952
2015
Q1
$531K Buy
+11,770
New +$525K ﹤0.01% 2013
2014
Q4
Sell
-75,319
Closed -$3.75M 2229
2014
Q3
$3.75M Buy
75,319
+8,825
+13% +$442K 0.02% 768
2014
Q2
$3.33M Buy
66,494
+11,041
+20% +$539K 0.02% 828
2014
Q1
$2.87M Buy
55,453
+4,164
+8% +$200K 0.02% 829
2013
Q4
$2.44M Buy
51,289
+12,275
+31% +$539K 0.02% 838
2013
Q3
$1.53M Buy
+39,014
New +$1.62M 0.01% 1010

Other funds holding CMA

Raymond James & Associates's CMA Position: Q3 2024 in Review

Raymond James & Associates reduced its Comerica (CMA) stake by 33% in Q3 2024, selling an estimated $2.6M and leaving 98,002 shares worth $5.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Raymond James & Associates first reported a position in CMA in Q3 2013 and has held it in 43 quarters since. The position peaked at $18.5M in Q1 2021. 530 funds tracked by Wall St. Rank hold CMA as of Q3 2024.

  • Raymond James & Associates held 98,002 shares of Comerica worth $5.87M as of Q3 2024.
  • Raymond James & Associates sold 47,231 Comerica shares in Q3 2024, an estimated $2.6M.
  • Comerica made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1547 holding.
  • Raymond James & Associates first reported a position in Comerica in Q3 2013 and has held it in 43 quarters since.
  • Raymond James & Associates's Comerica position peaked at $18.5M in Q1 2021.
  • 530 funds tracked by Wall St. Rank held Comerica as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.